AccessMyLibrary provides FREE access to millions of articles from top publications available through your library.

Index of articles > Business > Trade Industries publications > Chemical Business Newsbase articles > March 2008 articles
Close

Create a link to this page

Copy and paste this link tag into your Web page or blog:

<a href="http://www.accessmylibrary.com/article-1G1-188427349/teva-sues-fda-over.html" title="Facts and information about Teva sues FDA over generic Risperdal exclusivity.">Teva sues FDA over generic Risperdal exclusivity.</a>
Close Set up an RSS feed that alerts you when new articles from Chemical Business Newsbase are available.
XML Add to My Yahoo! Add to My AOL Add to Google Subscribe in NewsGator
Frequently asked questions about RSS feeds

Teva sues FDA over generic Risperdal exclusivity.

Chemical Business Newsbase

| March 31, 2008 | COPYRIGHT 2000 Elsevier Engineering Information, Inc. (Hide copyright information)Copyright

Teva Pharmaceuticals has begun legal action against the US FDA after the agency refused to restore the firm's 180-day exclusivity for the generic version of Janssen …

View articles courtesy of your local library
Related articles from newspapers, magazines, journals, and more
©2013 Gale, a part of Cengage Learning. All rights reserved. Contact us | Privacy policy | Terms and conditions

The AccessMyLibrary advertising network includes: womensforum.com GlamFamily